Inotek to consider strategic options after eye drug fails another study
July 07, 2017 at 16:36 PM EDT
July 7 (Reuters) - Inotek Pharmaceuticals Corp said on Friday it would evaluate its lead experimental drug and consider strategic options after the eye drug failed another trial.